Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bayer reports novel candidate cancer therapeutics

Feb. 13, 2012

Zhe-Jiang Beta Pharma presents novel PARP-1 inhibitors

Feb. 13, 2012

New anticancer products developed

Feb. 13, 2012

Dicerna Pharmaceuticals patents new RNA-based products

Feb. 13, 2012

Pfizer launches Inlyta in U.S.

Feb. 13, 2012

Algeta reports updated data from phase III ALSYMPCA trial

Feb. 13, 2012

Sanofi prepares novel fibroblast growth factor receptor antagonists

Feb. 13, 2012

TOCA therapy increases survival in models of brain cancer

Feb. 13, 2012

FDA advisory committee issues vote on Dacogen sNDA

Feb. 10, 2012

Jubilant and Endo Pharmaceuticals nominate anticancer candidate

Feb. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...